Company Filing History:
Years Active: 2022
Title: Innovations in Veterinary Vaccines by Karin Huberdina Antonia Van Der Heijden-Liefkens
Introduction
Karin Huberdina Antonia Van Der Heijden-Liefkens is a notable inventor based in Veghel, Netherlands. He has made significant contributions to the field of veterinary vaccines, particularly in the development of porcine vaccines against Porcine Circovirus Type 2 (PCV2) and associated diseases. His innovative work has the potential to enhance the health and productivity of swine populations.
Latest Patents
Karin holds a patent for the recombinant expression of PCV2b ORF2 protein in insect cells. This invention addresses a critical need in veterinary medicine by introducing a mutation in the PCV2b ORF2 protein to prevent its nuclear accumulation when expressed in insect cells. The mutation involves the introduction of a Proline at amino acid position 131, which facilitates efficient expression in insect cells, allows for easy harvesting, and generates large amounts of virus-like particles (VLPs). These VLPs are highly effective in vaccines aimed at reducing infection by PCV2 and alleviating associated signs of disease.
Career Highlights
Karin is currently associated with Intervet Inc., a company known for its commitment to animal health and innovative veterinary solutions. His work has been instrumental in advancing the field of veterinary vaccines, contributing to improved health outcomes for livestock.
Collaborations
Karin has collaborated with notable colleagues, including Paulus Jacobus Antonius Sondermeijer and Lisette Sanders. These collaborations have fostered a productive environment for innovation and research in veterinary medicine.
Conclusion
Karin Huberdina Antonia Van Der Heijden-Liefkens is a pioneering inventor whose work in veterinary vaccines is making a significant impact on animal health. His innovative approaches and collaborations are paving the way for advancements in the prevention of diseases in swine populations.